𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Antiphospholipid Antibodies and the Risk of Thromboembolic Events in Valvular Heart Disease

✍ Scribed by Bulckaen, Hélène G.; Puisieux, François L.; Bulckaen, Emmanuel D.; Di Pompeo, Christophe; Bouillanne, Olivier M.; Watel, Annie A.; Fauchais, Anne-Laure M.; De Groote, Pascal; Millaire, Alain

Book ID
123215410
Publisher
Mayo Clinic
Year
2003
Tongue
English
Weight
82 KB
Volume
78
Category
Article
ISSN
0025-6196

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bromocriptine use and the risk of valvul
Bromocriptine use and the risk of valvular heart disease
✍ Louis C.S. Tan; Kenneth K.C. Ng; Wing-Lok Au; Raymond K.K. Lee; Yiong-Huak Chan; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

## Abstract It has been reported that patients on pergolide and carbergoline have an increased risk of developing valvular heart disease. It is uncertain if bromocriptine, an ergot‐derived dopamine agonist (DA) with partial 5‐HT~2B~ activity, is associated with a similar risk. We assessed the frequ